Document Classification

Section Type: RESULTS

Text: Subgroup analysis showed that DeltaCD62P [(7. 50 + / - 19. 35) % vs. (3. 24 + / - 11. 18) % vs. (2. 53 + / - 8. 87) %], DeltaPAC-1 [(13. 40 + / - 24. 62) % vs. (11. 28 + / - 19. 90) % vs. (10. 11 + / - 21. 29) %] and DeltaMPAR [(7. 56 + / - 19. 11) % vs. (7. 87 + / - 23. 60) % vs. (6. 75 + / - 23. 30) %] in ACS patients were also similar among three groups (all P > 0. 05).